Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
 
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
by Tsvetelina Velikova, Metodija Sekulovski, Simona Bogdanova, Georgi Vasilev, Monika Peshevska-Sekulovska, Dimitrina Miteva and Tsvetoslav Georgiev
 
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
 
Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect
by Toshihiko Tashima
 
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
 
Recent Progress in Antibody Epitope Prediction
by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
 
IgY Antibodies as Biotherapeutics in Biomedicine
by Diana León-Núñez, María Fernanda Vizcaíno-López, Magdalena Escorcia, Dolores Correa, Elizabeth Pérez-Hernández and Fernando Gómez-Chávez
 
A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)
by Kristin Widyasari and Jinnam Kim
 
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
by Sara Gómez-Melero and Javier Caballero-Villarraso
 
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier
by Toshihiko Tashima
Views Article
Elevated IgE Levels—An Allergy or an Underlying Inborn Error of Immunity in Children with Recurrent Infections?
by Polina Kostova, Vera Papochieva, Dimitrinka Miteva, Bilyana Georgieva, Sirma Mileva, Martin Shahid, Tsvetelin Lukanov and Guergana Petrova
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by Marino Paroli and Maria Isabella Sirinian
New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond
by Marino Paroli, Chiara Gioia and Daniele Accapezzato
IgA Nephropathy: Current Treatment and New Insights
by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy
by Christopher Chung, Sagar B. Kudchodkar, Curtis N. Chung, Young K. Park, Ziyang Xu, Norbert Pardi, Mohamed Abdel-Mohsen and Kar Muthumani
From Cereal Grains to Immunochemistry—What Role Have Antibodies Played in the History of the Home Pregnancy Test
by Kinga Lis
Recent Progress in Antibody Epitope Prediction
by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
Downloads Article
The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease
by Hernando Vargas-Uricoechea, Juan Patricio Nogueira, María V. Pinzón-Fernández and Diego Schwarzstein
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier
by Toshihiko Tashima
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants
by Alain Beck, Christine Nowak, Deborah Meshulam, Kristina Reynolds, David Chen, Dennis B. Pacardo, Samantha B. Nicholls, Gregory J. Carven, Zhenyu Gu, Jing Fang, Dongdong Wang, Amit Katiyar, Tao Xiang and Hongcheng Liu
IgA Nephropathy: Current Treatment and New Insights
by Dimitra Petrou, Petros Kalogeropoulos, George Liapis and Sophia Lionaki
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
by Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N. Davidyuk, Aygul Valiullina, Albert Rizvanov and Emil Bulatov
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
by Lucas Jacobs, Nader Wauters, Yahya Lablad, Johann Morelle and Maxime Taghavi
Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect
by Toshihiko Tashima
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
by Sara Gómez-Melero and Javier Caballero-Villarraso
Recent Progress in Antibody Epitope Prediction
by Xincheng Zeng, Ganggang Bai, Chuance Sun and Buyong Ma
New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond
by Marino Paroli, Chiara Gioia and Daniele Accapezzato
Back to TopTop